Lundbeck Set For 'Transformative' Eptinezumab Launch

February 21 PDUFA Date For Migraine Drug

 
• By Kevin Grogan
  
Lundbeck
Strong 2019 for the Danish pharma firm • Source: Lundbeck
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business